# Aurinia Pharmaceuticals Inc. (AUPH) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Aurinia Pharmaceuticals Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AUPH/mda/fy2025/): filed 2026-02-26; accession 0001600620-26-000017 (https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AUPH/mda/fy2024/): filed 2025-02-27; accession 0001600620-25-000011 (https://www.sec.gov/Archives/edgar/data/1600620/000160062025000011/auph-20241231.htm)
- [FY 2023 MD&A](/company/AUPH/mda/fy2023/): filed 2024-02-15; accession 0001600620-24-000012 (https://www.sec.gov/Archives/edgar/data/1600620/000160062024000012/auph-20231231.htm)
- [FY 2022 MD&A](/company/AUPH/mda/fy2022/): filed 2023-02-28; accession 0001628280-23-005341 (https://www.sec.gov/Archives/edgar/data/1600620/000162828023005341/auph-20221231.htm)
- [FY 2021 MD&A](/company/AUPH/mda/fy2021/): filed 2022-02-28; accession 0001628280-22-004082 (https://www.sec.gov/Archives/edgar/data/1600620/000162828022004082/auph-20211231.htm)

Back to /company/AUPH/